Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.89 | N/A |
| PEG Ratio (TTM) | 0.96 | N/A |
| P/S Ratio (TTM) | 5.60 | N/A |
| P/B Ratio (TTM) | 0.93 | N/A |
| P/FCF Ratio (TTM) | 13.56 | N/A |
| Price to 5YR AVG Earnings Ratio | 37.95 | N/A |
| Price to 5YR AVG FCF Ratio | -16.85 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.01% | N/A |
| ROE (TTM) | 4.22% | N/A |
| Net Profit Margin (TTM) | 25.19% | N/A |
| ROIC 5YR AVG | 2.76% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 453.42% | 28.52% | 2.90% |
| Revenue | 2.13% | 16.87% | 16.91% |
| Net Income | 408.87% | 44.93% | 15.96% |
| Cash Flow | 4.70% | 21.14% | 23.51% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.30 | N/A |
| Quick Ratio (TTM) | 0.30 | N/A |
| D/E Ratio (TTM) | 0.70 | N/A |
| Interest Coverage (TTM) | 7.00 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.75 | N/A |
| LTL to 5YR AVG FCF | -11.44 | N/A |
| Shares Outstanding Growth 5YR AVG | 10.72% | N/A |